MS4A1 and neoplasm: Bispecific T cell engaging antibodies are antibody constructs with two or more antigen binding domains, one recognizing a tumor antigen, such as the B cell maturation antigen (BCMA), CD19 or CD20, and the other recognizing CD3 on T cells, which is essential for T cell receptor-mediated T cell activation [8].